Postoperative Atrial Fibrillation

L. Shen
{"title":"Postoperative Atrial Fibrillation","authors":"L. Shen","doi":"10.1093/med/9780190082482.003.0012","DOIUrl":null,"url":null,"abstract":"This chapter focuses on postoperative atrial fibrillation (POAF), which is very common after cardiothoracic surgery. Prevention of POAF involves continuation of preoperative beta-blockers, initiation of postoperative beta-blockers, and consideration of initiation of preoperative amiodarone in high-risk groups. In all patients, initial management of POAF includes correcting hypoxia and electrolyte abnormalities and consideration of weaning stimulating agents such as inotrope infusions. Medical management of hemodynamically stable patients includes the use of rate control agents such as beta-blockers, calcium-channel blockers, and digoxin or rhythm control agents such as amiodarone. When the patient is hemodynamically unstable, emergent synchronized cardioversion should be performed. Meanwhile, in refractory cases of rapid POAF, an aggressive rate control strategy may be pursued using one or more medications, but this approach must be weighed against the risk of requiring temporary or permanent pacing. Atrial flutter also occurs after cardiothoracic surgery, though at lower rates than POAF. It may be managed similarly to POAF, but it is typically more amenable to electrical cardioversion.","PeriodicalId":207135,"journal":{"name":"Cardiothoracic Critical Care","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiothoracic Critical Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780190082482.003.0012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This chapter focuses on postoperative atrial fibrillation (POAF), which is very common after cardiothoracic surgery. Prevention of POAF involves continuation of preoperative beta-blockers, initiation of postoperative beta-blockers, and consideration of initiation of preoperative amiodarone in high-risk groups. In all patients, initial management of POAF includes correcting hypoxia and electrolyte abnormalities and consideration of weaning stimulating agents such as inotrope infusions. Medical management of hemodynamically stable patients includes the use of rate control agents such as beta-blockers, calcium-channel blockers, and digoxin or rhythm control agents such as amiodarone. When the patient is hemodynamically unstable, emergent synchronized cardioversion should be performed. Meanwhile, in refractory cases of rapid POAF, an aggressive rate control strategy may be pursued using one or more medications, but this approach must be weighed against the risk of requiring temporary or permanent pacing. Atrial flutter also occurs after cardiothoracic surgery, though at lower rates than POAF. It may be managed similarly to POAF, but it is typically more amenable to electrical cardioversion.
术后心房颤动
本章的重点是术后心房颤动(POAF),这是心胸外科手术后非常常见的。预防POAF包括术前继续使用β受体阻滞剂,术后开始使用β受体阻滞剂,高危人群术前考虑开始使用胺碘酮。在所有患者中,POAF的初始治疗包括纠正缺氧和电解质异常,并考虑使用脱机刺激剂,如肌力输注。血流动力学稳定患者的医疗管理包括使用速率控制药物,如-受体阻滞剂、钙通道阻滞剂和地高辛或节律控制药物,如胺碘酮。当患者血流动力学不稳定时,应进行紧急同步心律转复。同时,在难治性快速POAF病例中,可以采用一种或多种药物来积极控制心率,但这种方法必须与需要临时或永久起搏的风险进行权衡。心房扑动也发生在心胸外科手术后,但发生率低于POAF。它的治疗方法可能与POAF相似,但通常更适合电复律。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信